News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Nivolumab-ipilimumab combo plus surgery improves survival in HCC
11 Feb 2026
byStephen Padilla
Patients with potentially resectable hepatocellular carcinoma (HCC) may receive neoadjuvant nivolumab plus ipilimumab therapy, followed by surgery, to improve their survival, suggests a study.
Nivolumab-ipilimumab combo plus surgery improves survival in HCC
11 Feb 2026
Harnessing the microbiome for autism: From diagnosis to treatment
11 Feb 2026
byKanas Chan
Modulation of the gut microbiota may be an effective therapeutic approach for autism spectrum disorder (ASD). A noninvasive test using a panel of multikingdom microbiome and functional markers is available to help diagnose ASD.







